Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hyperphagia 3Short Bowel Syndrome 2Pena Shokeir syndrome, type 1 2Sepsis 1Neoplasms 1Malnutrition 1Inflammation 1Infections 1Ileus 1Bites and Stings 1Advanced Malignant Neoplasm 1

Interventions

Gemcitabine 57Paclitaxel 50Cyclophosphamide 45pembrolizumab 44Carboplatin 41Bevacizumab 38Cisplatin 33Docetaxel 31Fluorouracil 30Nivolumab 29Capecitabine 29Pemetrexed 24Irinotecan 24Oxaliplatin 23Dexamethasone 23Ipilimumab 22Leucovorin 21Radiotherapy 20Sorafenib 19Doxorubicin 19Everolimus 18Cetuximab 18fludarabine 17Albumin-Bound Paclitaxel 17trametinib 15Sunitinib 15Rituximab 15Erlotinib Hydrochloride 15130-nm albumin-bound paclitaxel 15Prednisone 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasms × soybean oil, phospholipid emulsion × Clear all
NCT01943409 2025-02-03

Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils

University Health Network, Toronto

Phase 4 Completed
303 enrolled 16 charts

Bites and Stings, Hyperphagia, Infections, Inflammation, Neoplasms, Sepsis, Malnutrition, Ileus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡